Examining the impact of real-world evidence on medical product development, I: Incentives: proceedings of a workshop--in brief

On September 19-20, 2017, the National Academies of Sciences, Engineering, and Medicine held the first workshop of a three-part series titled Examining the Impact of Real-World Evidence on Medical Product Development. The workshops are intended to advance discussions and common knowledge among key s...

Full description

Bibliographic Details
Main Author: Gee, Amanda Wagner
Corporate Authors: National Academies of Sciences, Engineering, and Medicine (U.S.) Forum on Drug Discovery, Development, and Translation, Examining the Impact of Real-World Evidence on Medical Product Development (Workshop) ( 2017, Washington, D.C.)
Other Authors: Kahn, Benjamin ([rapporteur]), Shore, Carolyn ([rapporteur])
Format: eBook
Language:English
Published: Washington, DC The National Academies Press 2018, February 2018
Series:Proceedings of a workshop--in brief
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02169nam a2200277 u 4500
001 EB002219913
003 EBX01000000000000001356874
005 00000000000000.0
007 tu|||||||||||||||||||||
008 240703 r ||| eng
100 1 |a Gee, Amanda Wagner 
245 0 0 |a Examining the impact of real-world evidence on medical product development, I: Incentives: proceedings of a workshop--in brief  |h Elektronische Ressource  |c National Academies of Sciences, Engineering, and Medicine ; Health and Medicine Division ; Board on Health Sciences Policy ; Forum on Drug Discovery, Development, and Translation ; prepared by Amanda Wagner Gee, Ben Kahn, and Carolyn Shore 
246 3 1 |a Incentives 
260 |a Washington, DC  |b The National Academies Press  |c 2018, February 2018 
300 |a 1 PDF file (9 pages) 
505 0 |a Includes bibliographical references 
700 1 |a Kahn, Benjamin  |e [rapporteur] 
700 1 |a Shore, Carolyn  |e [rapporteur] 
710 2 |a National Academies of Sciences, Engineering, and Medicine (U.S.)  |b Forum on Drug Discovery, Development, and Translation 
710 2 |a Examining the Impact of Real-World Evidence on Medical Product Development (Workshop) ( 2017, Washington, D.C.) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Proceedings of a workshop--in brief 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK481618  |3 Volltext 
082 0 |a 610 
520 |a On September 19-20, 2017, the National Academies of Sciences, Engineering, and Medicine held the first workshop of a three-part series titled Examining the Impact of Real-World Evidence on Medical Product Development. The workshops are intended to advance discussions and common knowledge among key stakeholders about complex issues relating to the generation and use of real-world evidence (RWE). The first workshop focused on how to align incentives to support the collection and use of RWE in health product review, payment, and delivery and how to address the barriers that impede the uptake and application of RWE. This publication briefly summarizes the presentations and discussions from the workshop